Recursion Secures $200M in Underwritten Class A Stock Offering
Recursion Pharmaceuticals priced an underwritten offering of 61,540,000 shares of its Class A common stock at $3.25 per share on October 15, 2026, with the company expecting total gross proceeds of approximately $200 million before deducting underwriting discounts and commissions and estimated offering expenses. All of the shares are being sold by Recursion, and the offering is expected to close on or about October 16, 2026, subject to satisfaction of customary closing conditions, according to…